cosmiclifeform: Like your take on this acquisition. It appears that many investors see it as shelling out more money on yet another venture that apparently has little or no income stream, while not realizing how Trace Genetics is a major building block to put DNAP on course. The EPO deal is another one...and there is more. How about Moffit? And, and, and...
I think at some point soon, the master plan will come together, and will be obvious to all. Your gifted way with words would have said this much better than mine; however, the puzzle just seems to be getting near completion. Perhaps we shall see yet another news release soon that could knock our socks off; well, at least jump start the pps. No two people see everything precisely the same, so I don't expect anyone else to totally agree...just offering my 2 cents.
News 
Market Data 
Discover 
AI
